Clinical Trials Browser

Phase EARLY_PHASE1 × Burkitt Lymphoma × 30 days × Clear all

NCT07429461 2026-02-24

Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia